Introduction: Earlier studies have identified a gap between guidelines and actual clinical diabetes care in Malaysia.
Introduction
Type 2 diabetes mellitus (T2DM) is a growing epidemic worldwide, especially in developing countries (1) . In Malaysia, the prevalence of diabetes has increased over the last three decades, and this rate is accelerating. In the fifth and latest National Health and Morbidity Survey (NHMS), conducted in 2015, the prevalence of diabetes in adults aged over 18 had increased by 17.5%, compared to 11.6% in 2006 and 15.2% in 2011 (2). The microvascular and macrovascular complications of diabetes have led to increased mortality and significant healthcare costs to both patients and the community. Therefore, a comprehensive and systematic care package for diabetes patients is needed, to target not only the glycaemic control but also the cardiovascular risk factors, to ameliorate the long-term complications.
There is currently a large evidence base to underpin the optimal management of diabetes. In previous worldwide audits of diabetes care, a wide variation in quality has been observed, both in terms of care process performance and target achievement (3, 4) . While the factors contributing to this variation are complex, Lee et al. (4) demonstrated that socio-economic circumstances play a significant part, meaning that European systems tend to display better performance than those in the rest of the world. In Malaysia, previous local studies conducted
Data collection
A structured review of the outpatient clinic cards, prescriptions and laboratory results was undertaken during each patient's clinic visit.
The process measures of clinical care were defined as measurements having been done for fasting blood glucose (FBG), blood pressure (BP) and calculation of body mass index (BMI) at every visit over the previous year; glycosylated haemoglobin (HbA1c) levels had to have been assessed at least once over the previous six months, and patients should have had screening of lipid profile, fundoscopic and foot examinations, and urine protein or microalbuminuria done annually.
Data collected on intermediate outcome measures included the most recent HbA1c, FBG, BP and low-density lipoprotein cholesterol (LDL-C) levels, and BMI over the past year; the number of patients receiving statin, aspirin, angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB). The clinical outcome of diabetes care was defined as good control if the documented values were FBG < 6.1 mmol/L, HbA1c < 6.5%, LDL-C < 2. 
Data analysis
Statistical analysis was performed using SPSS version 16.0 (SPSS, Chicago, IL, USA). All data represented the most recent results available within the preceding 12 months. Descriptive data were expressed as mean value (with standard deviation) unless otherwise specified. As this was a clinical audit of diabetes care, ethical approval was considered not to be necessary.
Results
Of the total 275 patients who attended the diabetic clinic during the study period, 42 were excluded (26 patients were T1DM, 11 had been followed up for less than 12 months, while five had been newly diagnosed with diabetes for less than 12 months), leaving 233 patients for the statistical analysis. Their demographic and clinical characteristics are presented in Table 1 . Mean age (SD) of the patients was 56 (11.7) years old; mean duration of diabetes was 12.6 years, at both tertiary and primary care levels have highlighted the inadequacy of both glycaemic control and the management of the associated cardiovascular risk factors (5) (6) (7) (8) (9) . Accordingly, we conducted a clinical audit to assess the quality of care for T2DM patients who were followed up in our Diabetes Clinic.
Methods and Materials

Setting
The audit was conducted in the diabetes clinic in Sibu Hospital, a district hospital with major specialists. The hospital's Research Review Committee accepted this research work as a hospital-based internal audit, due to the use of depersonalised clinical data and achievements. This 630-bed public hospital not only services a direct population of 278,300 from Sibu, but is also a referral centre for the central zone of Sarawak, including Sarikei, Mukah and Kapit divisions, which have an additional combined population of up to 421,000. The diabetes clinic runs once a week every Wednesday afternoon and receives referrals of difficult diabetes cases, providing treatment and follow-up for diabetes and associated medical illnesses. In 2014, the clinic registered about 550 patients, who attended every three to four months on average. Each clinic was run by four resident medical officers and one general physician. There are two diabetic educators providing a counselling service to an average of five to six patients every session, as well as two pharmacists offering medication counselling for up to six patients per session. For individuals who require dietary counselling, a dietitian referral is made and a separate appointment provided. There is no podiatrist at Sibu Hospital.
Study population
The audit was done in October and November 2014. All patients attending the diabetic clinic during this period were screened.
Inclusion and exclusion criteria
The subjects included in the audit were 18 years old and above, had been diagnosed with T2DM more than one year previously, and had been followed up at the medical or diabetic clinics at Sibu Hospital for at least 12 months. Type 1 diabetes, gestational diabetes and diabetes that was secondary to other causes were excluded from this audit.
with almost half of the participants having been sufferers for more than 10 years. The majority of our patients were Chinese (55.3%), followed by Sarawak Natives (33.9%), Malay (9.9%) and other races (0.9%).
The process measures of diabetes care are summarised in Table 2, while Table 3 shows the achievement for the intermediate outcome measures.
Glycaemic control
The prevalence of the recording of fasting blood sugar (FBS) during every clinic visit was 99.1%, while the rate of HbA1c being recorded at least once over the preceding six months was 79.7%. Among the 195 patients who had had HbA1c done, the mean (SD) HbA1c level was 9.2% (1.91%), with 13 (6.7%) having HbA1c of less than 6.5% and 22 (11.3%) having HbA1c of 
Discussion
The National Diabetes Registry (NDR) Report Volume 1 (2009-2012) (10) , which evaluated diabetes care in Malaysian governmental primary healthcare clinics run by the Ministry of Health, reported a goal attainment rate of 23.8% for HbA1c < 6.5%, 40.9% for BP < 130/80 mmHg and 37.8% for LDL of < 2.6 mmol/L in 2012. This HbA1c achievement was better than what was found in our audit, which could be explained by the variance in study population characteristics. Our diabetes clinic is designed to receive referrals for patients with poor or challenged sugar control, while patients with good sugar control would be discharged to the polyclinic for further treatment. In addition, our patients are mostly longstanding diabetics, with a mean duration of the disease of 12.6 (7.33) years, and 48.9% had had it for more than 10 years. In contrast, the mean duration of diabetes in the NDR (2012) was six years, with 48.5% of patients having been sufferers for less than five years. Early-stage diabetes is, in relative terms, less challenging in terms of sugar and BP control. This is further illustrated by the insulin usage of only 21.4% in the NDR (2012), as compared to 80.7% in our audit. The BP control < 130/80 mmHg was comparable (40.6% in the NDR (2012) versus 36.4% in our audit), while our LDL < 2.6 mmol/L achievement was better (37.8% in the NDR (2012) versus 69.4% in our audit). Poor LDL achievement in the NDR (2012) was likely due to limited higher potency statin at the primary care setting. Additionally, more patients in our audit (88.4%) were receiving statin therapy as opposed to 62.3% in the NDR (2012).
Compared to other hospitals, our HbA1c goal attainment was again unsatisfactory, but blood pressure and lipid control were better. In the Diabcare-Asia project of 2003 (Malaysia), in which similar diabetes clinics were studied in 19 public hospitals across Peninsular Malaysia, HbA1c < 7% rate was significantly higher at 41%, but only 15% achieved BP < 130/80 mmHg and 32% achieved total cholesterol < 4.8 mmol/L (11). In another study of 2005 conducted in a general medical clinic at a local nearby tertiary centre in Sarawak, the HbA1c < 7% rate was 26%, BP < 130/80 mmHg rate was 32% and LDL < 2.6 mmol/L rate was 56% (12) . less than 7%. The mean FBG was 9.4 mmol/L, with only 23.3% having achieved FBS of no more than 6.1 mmol/L. Most (80.7%) of the patients received insulin therapy (with or without oral hypoglycaemic agents), while only 3% had oral monotherapy and 15.9% had oral combination therapy without insulin.
Blood pressure
Almost all patients (99.6%) had their BP recorded at every clinic visit. Mean systolic BP was 137 mmHg, while mean diastolic BP was 71 mmHg. Only about one-third (36.4%) of the patients had achieved a BP target of no more than 130/80 mmHg, despite most receiving multiple oral anti-hypertensives. Approximately 50% of the participants had received three or more oral anti-hypertensive agents, whereas those on two agents, single agents or not on anti-hypertensives were 26.6%, 16.3% and 7.3% respectively.
Lipid management
The rate of annual testing for fasting lipid profile was 99.6% among the patients, while 88.4% had received statin treatment. Mean LDL level was 2.4 mol/L, with nearly 70% having achieved a target level of no more than 2.6 mmol/L.
Body mass index
92.6% of the patients had their BMI recorded during every visit. The mean (SD) BMI was 28.5 (4.63) kg/m 2 . Out of 222 patients who had BMI recorded, more than 90% were overweight with BMI of more than 23, while only 19 (8.6%) had BMI of less than 23. In addition, 67.4% (157/233) of the patients in this audit were on metformin therapy. Interestingly, the BMI was not significantly different between those who received metformin and those who did not (BMI 28.1 (4.80) kg/m 2 for those on metformin versus 28.7 (4.56) kg/m 2 for those not; result not shown). Besides metformin, the use of other relatively weighty neutral anti-diabetes measures was minimal, as only one respondent was on subcutaneous enaxetide while five were on Dipeptidyl peptidase-4 inhibitor (DPPIV-i).
Complication screening
The screening rate for albuminuria by urine dipstick was as high as 93.6%. However, out of 145 patients with negative or trace urine albumin, only 29 (20%) were tested further for urine microalbumin. 71% of patients had had eye screening during the previous year, while only Among the complications screenings, only nephropathy screening was relatively satisfactory, with 93.6% of patients having a urine dipstick performed at least yearly, while 71.2% had an annual eye screening and only 25.8% had their feet checked each year. The nephropathy screening could be further refined by improving the microalbuminuria detection rate, since only 20% of patients with negative proteinuria had microalbuminuria tested in this audit. The low foot examination rate is most likely due the time-consuming nature of these assessments for a busy diabetes clinic, which is possibly exacerbated by the lack of a podiatrist at our centre. However, shifting the responsibility for these exams to diabetic educators could improve diabetes patients' foot care and allow more time for physicians to concentrate on other aspects of patient care.
The accuracy of our audit is limited by the possibility of undocumented clinical variables, as this is a retrospective data collection. Second, patient knowledge, attitudes, practice and HBGM were not assessed in this audit. Similarly, different physicians' knowledge and perceptions, which may contribute to their level of care for patients, were not assessed in this study.
Conclusion
This audit highlighted the challenges inherent in the optimisation of diabetes care at our centre, especially as regards weight management and glycaemic control in chronic and longstanding diabetes.
